AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03347695 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Left Atrial Geometric Volume Reduction, Pulmonary Vein Island Isolation and Left Appendage Base Closure(selected patients)
Description: Left Atrial Geometric Volume Reduction, Pulmonary Vein Island Isolation and Left Appendage Base Closure
Study NCT03347695 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Left Atrial Geometric Volume Reduction, Pulmonary Vein Island Isolation and Left Appendage Base Closure
Description: Left Atrial Geometric Volume Reduction, Pulmonary Vein Island Isolation and Left Appendage Base Closure
Study NCT03212196 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pancreaticogastrostomy with external drain
Description: Pancreatico-enteric anastomosis is provided according to the Bassi technique, pancreatic remnant is pushed into the gastric cavity through a posterior gastrotomy. An externalized drain is placed into the main pancreatic duct.
Study NCT01477996 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 30-gauge
Description: 30-gauge needle for IVT
Study NCT04308499 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital cognitive-behavioral therapy for insomnia (dCBTI)
Description: Internet-based cognitive-behavioral therapy for insomnia (CBT-I) structured into 6 weekly sessions accessed using either a computer or a smartphone
Study NCT04308499 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sleep hygiene education (SHE)
Description: Recognized and commonly prescribed set of sleep hygiene instructions comprised of comprise a website and a downloadable booklet
Study NCT03878615 — intervention group
Intervention type: PROCEDURE
Intervention: elective surgery, according to deprtement routine
Description: none, descriptive study
Study NCT04263441 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: NICE Intervention
Description: Subjects enrolled in the intervention arm will be offered assistance in enrolling in healthcare coverage and provided assistance on where they can go for care immediately. Subjects will be followed for 1 year and information including lab tests and insurance coverage status will be collected. This information will be collected from medical record review.
Study NCT03212196 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pancreaticojejunostomy with transanastomotic drain
Description: Pancreatico-enteric anastomosis is provided through a double-layer, duct-to-mucosa anastomosis with a transanastomotic externalized drain.
Study NCT04690231 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apatinib Mesylate
Description: apatinib orally daily and ifosfamide 1.8mg/m2/d d1-3, etoposide 100mg/m2/d d1-3
Study NCT04690231 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ifosfamide and etoposide
Description: ifosfamide and etoposide
Study NCT04463433 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive and behavioral intervention.
Description: Two hours group sessions including mindfulness and emotion regulation. The practice of mindfulness is taught to parents to become aware of their thoughts and emotion on the present moment. The behavioral intervention has parents develop an Positive Time-out for dealing with conflict and negativity, using strategies to down-regulate their own negative emotions.
Study NCT04463433 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Problem-solving and relationship improvement intervention.
Description: Two hours group sessions including problem-solving and improving marital relationship . In the problem-solving part, the knowledge and techniques of problem-solving are taught to couple. relationship improvement part which promote the couple relationship by being aware of their own and their partner's deep-seated needs and communicating in a congruent way.
Study NCT01070641 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carvedilol
Description: Carvedilol 12.5mg QD
Study NCT01070641 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Esophageal variceal band ligation
Description: Each patient will undergo for variceal band ligation after 3 weeks till the eradication of varices
Study NCT03277781 — intervention group
Intervention type: OTHER
Intervention: Screening
Description: Screening for AAA
Study NCT02585674 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin glargine (U300)
Description: Pharmaceutical form: solution for injection~Route of administration: subcutaneous
Study NCT02585674 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin glargine (U300)
Description: Pharmaceutical form: solution for injection~Route of administration: subcutaneous
Study NCT02585674 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MyStar DoseCoach
Description: Glucose meter
Study NCT03247283 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986205
Description: Carbon 14 tagged BMS-986205
Study NCT04690231 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ifosfamide and etoposide
Description: ifosfamide and etoposide
Study NCT03925038 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Augmented Care: Electronic Media Dashboard
Description: A participant-specific dashboard that highlights patterns of patient electronic communication usage relevant to understanding participants' mental health will be developed and used to augment treatment as usual.
Study NCT03925038 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment as Usual
Description: Participants will receive psychotherapy as treatment as usual.
Study NCT03925038 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual
Description: Participants will receive psychotherapy as treatment as usual.
Study NCT02130089 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Intensive Tailored Education
Study NCT03082157 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mighty Men Intervention
Description: African American men assigned to this condition will receive: tailored goals/ messages, self-monitoring, small group meetings and educational and community-based information and resources.
Study NCT03256929 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personalized Diet-driven microbiota
Description: Based on the results of the individual microbiota profile, the investigators will formulate a specific diet aiming to enrich the distinct microbiota with organisms correlated to better mental health. The dietitian will visit each participant twice a month.
Study NCT03256929 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: General information on nutrition and health
Description: General information on nutrition and health. The dietitian will visit each participant twice a month.
Study NCT03381079 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Posterior scleral reinforcement
Description: Posterior scleral reinforcement (pPSR) is a procedure applied with autologous or biological material or synthetic materials reinforcing pole of the sclera after eyeball, in order to prevent or alleviate myopic development.
Study NCT04517201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: iNCDSS based insulin regime
Description: Patients of this group will receive the insulin regime set by the AI assisted insulin titration system (iNCDSS).
Study NCT01831063 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Simulation
Description: The experimental group received a simulation based seizure teaching session in addition to the traditional seizure teaching
Study NCT04336956 — intervention group
Intervention type: OTHER
Intervention: hospitalized children with Covid19
Description: All patients under 18 years hospitalized with a covid19 diagnosis
Study NCT04193631 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD)
Description: A single dose of Cannabidiol (CBD) when patients experience musculoskeletal pain in the trial.
Study NCT00727454 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CPAP
Description: Continuous Positive Airway Pressure (CPAP) during sleep for 3 months.
Study NCT04517201 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Physician based insulin regime
Description: Patients of this group will receive the insulin regime recommended by professional endocrinologists.
Study NCT03300635 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Mental distress and relaxation test
Study NCT04860947 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Spinal Cord MRI
Description: Sagittal T2 Sagittal T1 with Gadolinium injection
Study NCT00727454 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: No treatment
Description: No treatment
Study NCT01713309 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Filgrastim
Description: Filgrastim 300 ug daily for 7 days, subcutaneously.
Study NCT03507439 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AVIVO Mobile Patient Management (MPM) System
Description: Wearable, wireless physiological monitoring and arrhythmia detection system, used by participants for 5 monitoring periods of 5 days each in the study
Study NCT04860947 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Retinal imaging
Description: spectral-domain high definition optical coherence tomography
Study NCT00795457 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GAA/TT-peptide vaccine and poly-ICLC
Description: Participants will be treated with subcutaneous injections of GAA/TT-vaccines on Weeks 0, 3, 6, 9, 12, 15, 18 and 21. I.m. poly-ICLC will be administered (20 mg/kg i.m.) on the day of, and on day 4 after each vaccine (e.g. if the vaccine is administered on Thursday, poly-ICLC will be administered on the day of vaccine and the following Monday). Each vaccine will be administered within 2 hours before or after the i.m. poly-ICLC administration.
Study NCT03507439 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VitalPatch biosensor
Description: Wearable, wireless physiological monitoring and arrhythmia detection system, used by participants for 5 monitoring periods of 5 days each in the study
Study NCT03507439 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DynaPort Move Monitor
Description: Wearable device for ambulatory monitoring of physical activity, used by participants for 2 monitoring periods of 7 days each in the study
Study NCT01259427 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ending Self Stigma (ESS)
Description: Ending Self Stigma (ESS) is a 9-session small-group (4-8 persons) course designed to help individuals with serious mental Illness (SMI) develop skills to effectively cope with stigma and minimize the internalization of stigmatizing beliefs and stereotypes. Sessions combine in-class lecture, discussion of relevance to group members' personal experiences, review and practice of strategies and skills, and group sharing, support, and problem-solving. Each session is designed to focus on a specific strategy for addressing self-stigma.
Study NCT01259427 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health and Wellness Group
Description: The Health and Wellness group is a 9-session small-group (4-8 persons) course designed for individuals with serious mental illness (SMI). Each session focuses on discussion of specific health and wellness related issues and education on ways to better manage health related concerns (e.g., physical activity/exercise, nutrition, managing fatigue/sleep, tobacco and other substance use, etc).
Study NCT03760393 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: (SB-related planning + daily text messages)
Description: Participants will receive a one-on-one behavioral counseling session, and planning sheet as reference for developing strategies as part of their Action/Coping Plan. Participants will be asked to form 3-4 actions plans specifying when, where, how, and for how long they would reduce occupational (student) sitting time; and anticipate potential barriers and identify ways they could be overcome. Strategies will explicitly focus on the ultimate objective of increasing break frequency to every 30-45 minutes, achieving a break duration of 2-3 minutes, and increasing time spent standing and engaged in light-intensity PA, in the occupational domain (i.e. as a student; during school-related activities).~Participants will also receive sedentary behaviour-related text messages twice daily, depending on their preferences and schedule, which will act as mini-booster interventions.
Study NCT02140957 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Educational Intervention
Description: Parents of children in both intervention and control groups received standardized counseling on healthy nutrition based on Canadian Paediatric Society guidelines. In addition, during the same 9-month doctors visit, parents of infants allocated to the intervention group were given a sip cup (Avent Magic CupTM) and shown how to use it. A trained research assistant told intervention group parents the risks of continued bottle use. They were also instructed to limit daily milk consumption to 16 ounces. Parents were also counseled to discontinue bottle use in the next 1 week using a step-wise protocol described on a handout to be placed on their refrigerator. Parents of infants allocated to the control group did not receive this information.
Study NCT02140957 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational Intervention
Description: Parents of children in both intervention and control groups received standardized counseling on healthy nutrition based on Canadian Paediatric Society guidelines. In addition, during the same 9-month doctors visit, parents of infants allocated to the intervention group were given a sip cup (Avent Magic CupTM) and shown how to use it. A trained research assistant told intervention group parents the risks of continued bottle use. They were also instructed to limit daily milk consumption to 16 ounces. Parents were also counseled to discontinue bottle use in the next 1 week using a step-wise protocol described on a handout to be placed on their refrigerator. Parents of infants allocated to the control group did not receive this information.
Study NCT04326842 — intervention group
Intervention type: PROCEDURE
Intervention: Carotid artery revascularization procedure
Description: The patients with carotid artery stenosis will be examined before and after finishing the carotid artery revascularization procedure.
Study NCT04326842 — intervention group
Intervention type: DEVICE
Intervention: Optical coherence tomography angiography
Description: Examination will be performed using optical coherence tomography angiography. This device allows quantitative analysis, since it provides numerical data about flow area and flow density maps.
Study NCT01612000 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PanBlok
Description: Intramuscular injection
Study NCT01612000 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rHA adjuvant
Description: Intramuscular injection
Study NCT01068808 — intervention group
Intervention type: PROCEDURE
Intervention: skin prick test
Description: skin prick test to aeroallergen
Study NCT01201057 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.5% SPL7013 Gel
Description: Vaginal gel
Study NCT01201057 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 1.0% SPL7013 Gel
Description: Vaginal gel
Study NCT03300635 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Glucose tolerance test
Study NCT03300635 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Exercise test
Study NCT00604097 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Attachment-Based Family Therapy
Description: 12-16 week family-based therapy
Study NCT00604097 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care
Description: Rapid referral to community outpatient care with weekly monitoring of symptoms by study team
Study NCT01750697 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Participants will receive rituximab 375 mg/m\^2 IV infusion on Days 1, 8, 15 and 22. Rituximab infusions will be given at a rate of 25 milligrams per hour (mg/h). This may be escalated at a rate of 25 mg/h increments every 30 minutes to a maximum of 200 mg/h.
Study NCT04042714 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: All patients- TAS-102
Description: Patients will receive TAS-102, Orally, BID for 5 days a week with 2 days rest for 14 days, followed by a 14-day rest treatment cycle. Treatment may continue until disease progresses, intolerable toxicity is developed, or if the patient becomes pregnant or dies.
Study NCT03945747 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood draw
Description: Participants will undergo a blood collection for hemoglobin A1c, adiponectin, total cholesterol, LDL, HDL, triglycerides, and c-peptide at baseline and follow up in 3-6 months.
Study NCT03945747 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Urine sample collection
Description: Participants will undergo urine sample collection for urine microalbumin and urine creatinine at baseline and follow up in 3-6 months.
Study NCT03945747 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: DXA scan
Description: Participants will undergo a DXA scan for lean and fat mass measurements at baseline and follow up in 3-6 months.
Study NCT01749709 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music listening
Study NCT01749709 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Audiobook listening
Study NCT04348864 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: SHAM_COMPARATOR
Intervention: COVID-19 Antigen/Antibody Rapid Testing, mobile device image capture and telemedicine support
Description: An immunodiagnostic rapid (5-20 minute) test detects circulating antibodies in the blood, serum or plasma of individuals who have been infected with the novel coronavirus SARS-COV-2 as detected by rapid antigen test or LAMP/PCR-based molecular test taken from nasopharyngeal swab samples in the recent past.
Study NCT04348864 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: COVID-19 Antigen/Antibody Rapid Testing, mobile device image capture and telemedicine support
Description: An immunodiagnostic rapid (5-20 minute) test detects circulating antibodies in the blood, serum or plasma of individuals who have been infected with the novel coronavirus SARS-COV-2 as detected by rapid antigen test or LAMP/PCR-based molecular test taken from nasopharyngeal swab samples in the recent past.
Study NCT04348864 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Telemedicine
Description: Imaging of the test using the software application COVIDscanDX and upload to server by the subject and phone, video or messaging consult with a clinician for interpretation and instructions establishes the telemedicine (i.e. virtual point-of-care).
Study NCT04348864 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemedicine
Description: Imaging of the test using the software application COVIDscanDX and upload to server by the subject and phone, video or messaging consult with a clinician for interpretation and instructions establishes the telemedicine (i.e. virtual point-of-care).
Study NCT02398903 — intervention group
Intervention type: OTHER
Intervention: Blood samples for measurement of drug Css
Description: Blood samples for measurement of drug Css
Study NCT01201057 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3.0% SPL7013 Gel
Description: Vaginal gel
Study NCT01201057 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Gel
Description: Vaginal gel
Study NCT02521402 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Biovance
Description: decellularized, dehydrated human amniotic membrane
Study NCT03464487 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Low Glycemic Index Therapy Diet
Description: Low Glycemic Index Therapy Diet allows only carbohydrates with Glycemic Index less than 50 and also restricts daily carbohydrate intake to less than 40-60 gram per day.
Study NCT03051503 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: The Transdermal Therapeutic System-Fentanyl (TTS-F)
Description: (TTS-F) group (n=30) 50ug/h patch, placed 12 hours preoperatively
Study NCT03051503 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Intravenous patient-controlled analgesia (PCA) morphine
Description: IV PCA morphine for pain in the postoperative period.
Study NCT01741519 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LDLL600
Description: Comparison of 3 different doses LDLL600 in long-term infusion. 54 PK samples, BP and ECG measurement time points, several local tolerability measurement time points.
Study NCT01741519 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Brevibloc
Description: Comparison of 3 different doses Esmolol in long-term infusion. 54 PK samples, BP and ECG measurement time points, several local tolerability measurement time points.
Study NCT01836705 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAR302503 (TG101348)
Description: Pharmaceutical form:capsule~Route of administration: oral
Study NCT01836705 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo SAR302503
Description: Pharmaceutical form:capsule~Route of administration: oral
Study NCT01836705 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Panolosetron
Description: Pharmaceutical form:solution~Route of administration: intravenous
Study NCT01648348 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Anti-Endoglin Chimeric Monoclonal Antibody TRC105
Description: Given IV
Study NCT01648348 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Given IV
Study NCT01648348 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Bevacizumab
Description: Given IV